KR20080063048A - 발효인삼 또는 홍삼의 제조방법 - Google Patents
발효인삼 또는 홍삼의 제조방법 Download PDFInfo
- Publication number
- KR20080063048A KR20080063048A KR1020070103435A KR20070103435A KR20080063048A KR 20080063048 A KR20080063048 A KR 20080063048A KR 1020070103435 A KR1020070103435 A KR 1020070103435A KR 20070103435 A KR20070103435 A KR 20070103435A KR 20080063048 A KR20080063048 A KR 20080063048A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- lactobacillus
- lactic acid
- acid bacteria
- red ginseng
- Prior art date
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 113
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 108
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 108
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 95
- 238000000034 method Methods 0.000 title claims abstract description 47
- 241000208340 Araliaceae Species 0.000 title claims abstract 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 109
- 239000004310 lactic acid Substances 0.000 claims abstract description 54
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 54
- 241000894006 Bacteria Species 0.000 claims abstract description 51
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 claims abstract description 41
- 241000186660 Lactobacillus Species 0.000 claims abstract description 22
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 20
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 claims abstract description 16
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 claims abstract description 15
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 claims abstract description 15
- CKUVNOCSBYYHIS-LGYUXIIVSA-N 20(R)-Ginsenoside Rh2 Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1C(C)(C)[C@H]2[C@@](C)([C@H]3[C@](C)([C@@]4(C)[C@H]([C@H](O)C3)[C@@H]([C@](O)(CC/C=C(\C)/C)C)CC4)CC2)CC1 CKUVNOCSBYYHIS-LGYUXIIVSA-N 0.000 claims abstract description 15
- 241000192132 Leuconostoc Species 0.000 claims abstract description 14
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 9
- 238000012258 culturing Methods 0.000 claims abstract description 7
- 241000194017 Streptococcus Species 0.000 claims abstract description 5
- 241000192001 Pediococcus Species 0.000 claims abstract description 4
- 241000194033 Enterococcus Species 0.000 claims abstract description 3
- 241000194036 Lactococcus Species 0.000 claims abstract description 3
- 241000186429 Propionibacterium Species 0.000 claims abstract description 3
- 241000186715 Lactobacillus alimentarius Species 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 3
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 3
- 241000186612 Lactobacillus sakei Species 0.000 claims description 3
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 2
- 241001608472 Bifidobacterium longum Species 0.000 claims description 2
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 2
- 241000194032 Enterococcus faecalis Species 0.000 claims description 2
- 241000194031 Enterococcus faecium Species 0.000 claims description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 2
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 2
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 2
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 2
- 244000057717 Streptococcus lactis Species 0.000 claims description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 2
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 2
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 2
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 2
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 2
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 2
- 208000001613 Gambling Diseases 0.000 claims 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims 1
- 229910052719 titanium Inorganic materials 0.000 claims 1
- 239000010936 titanium Substances 0.000 claims 1
- 240000004371 Panax ginseng Species 0.000 description 100
- 229930182494 ginsenoside Natural products 0.000 description 38
- 229930182490 saponin Natural products 0.000 description 18
- 150000007949 saponins Chemical class 0.000 description 18
- 235000017709 saponins Nutrition 0.000 description 18
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 13
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 12
- 108020004465 16S ribosomal RNA Proteins 0.000 description 9
- 239000012141 concentrate Substances 0.000 description 8
- 229940089161 ginsenoside Drugs 0.000 description 8
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000021109 kimchi Nutrition 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241001527087 Panax vietnamensis Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 2
- VBUYCZFBVCCYFD-JJYYJPOSSA-N 2-dehydro-D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)C(O)=O VBUYCZFBVCCYFD-JJYYJPOSSA-N 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 2
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N D-Arabitol Natural products OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- GUBGYTABKSRVRQ-UHFFFAOYSA-N D-Cellobiose Natural products OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 2
- SHZGCJCMOBCMKK-SVZMEOIVSA-N D-fucopyranose Chemical compound C[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O SHZGCJCMOBCMKK-SVZMEOIVSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 2
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 2
- HEBKCHPVOIAQTA-IMJSIDKUSA-N L-arabinitol Chemical compound OC[C@H](O)C(O)[C@@H](O)CO HEBKCHPVOIAQTA-IMJSIDKUSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 2
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 235000017726 Panax vietnamensis Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 2
- PYMYPHUHKUWMLA-WISUUJSJSA-N aldehydo-L-xylose Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WISUUJSJSA-N 0.000 description 2
- 229930195726 aldehydo-L-xylose Natural products 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 2
- 229940089837 amygdalin Drugs 0.000 description 2
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000005757 colony formation Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940093496 esculin Drugs 0.000 description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 2
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 2
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 2
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 2
- 229960002413 ferric citrate Drugs 0.000 description 2
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 2
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 2
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 2
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 2
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 2
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 2
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 2
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 2
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 2
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 2
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 238000007731 hot pressing Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 2
- 229960002160 maltose Drugs 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 2
- DLRVVLDZNNYCBX-ABXHMFFYSA-N melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-ABXHMFFYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000004224 potassium gluconate Substances 0.000 description 2
- 229960003189 potassium gluconate Drugs 0.000 description 2
- 235000013926 potassium gluconate Nutrition 0.000 description 2
- GSFHMOMWXNDPMM-YMDUGQBDSA-M potassium;(2r,3s,4s)-2,3,4,6-tetrahydroxy-5-oxohexanoate Chemical compound [K+].OCC(=O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O GSFHMOMWXNDPMM-YMDUGQBDSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 240000003296 Petasites japonicus Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 238000010309 melting process Methods 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000035936 sexual power Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000002883 vasorelaxation effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/31—Leuconostoc
- A23V2400/321—Mesenteroides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
1 | 글라이세롤 (Glycerol) | - |
2 | 에리스리톨 (Erythritol) | - |
3 | D-아라비노즈 (D-Arabinose) | - |
4 | L-아라비노즈 (L-Arabinose) | + |
5 | D-리보스 (D-Ribose) | + |
6 | D-자일로스 (D-Xylose) | - |
7 | L-자일로스 (L-Xylose) | - |
8 | D-아도니톨 (D-Adonitol) | - |
9 | 메틸-bD-자일로피라노사이드 (Methyl-bD-Xylopyranoside) | - |
10 | D-갈락토스 (D-Galactose) | - |
11 | D-글루코스 (D-Glucose) | + |
12 | D-프록토스 (D-Fructose) | + |
13 | D-만노스 (D-Mannose) | + |
14 | L-소르보스 (L-Sorbose) | - |
15 | L-람노스 (L-Rhamnose) | - |
16 | 둘시톨 (Dulcitol) | - |
17 | 이노시톨 (Inositol) | - |
18 | D-만니톨 (D-Mannitol) | - |
19 | D-소르비톨 (D-Sorbitol) | - |
20 | 메틸-aD-만노피라노사이드 (Methyl-aD-Mannopyranoside) | - |
21 | 메틸-aD-글루코피라노사이드 (Methyl-aD-Glucopyranoside) | w |
22 | N-아세틸글루코사민 (N-Acetylglucosamine) | + |
23 | 아미그달린 (Amygdalin) | + |
24 | 아르부틴 (Arbutin) | + |
25 | 에스큘린 페릭 시트레이트 (Esculin ferric citrate) | + |
26 | 살리신 (Salicin) | + |
27 | D-셀로비오스 (D-Cellobiose) | + |
28 | D-말토스 (D-Maltose) | + |
29 | D-락토스 (D-Lactose) | - |
30 | D-멜리비오스 (D-Melibiose) | - |
31 | D-사카로스 (D-Saccharose) | + |
32 | D-트레할로스 (D-Trehalose) | + |
33 | 이눌린 (Inulin) | - |
34 | D-멜리지토스 (D-Melezitose) | - |
35 | D-라피노스 (D-Raffinose) | - |
36 | 아미돈 (전분) (Amidon (starch)) | w |
37 | 글라이코겐 (Glycogen) | - |
38 | 자일리톨 (Xylitol) | - |
39 | 젠티오비오스 (Gentiobiose) | + |
40 | D-투란노스 (D-Turanose) | - |
41 | D-락소스 (D-Lyxose) | - |
42 | D-타가토스 (D-Tagatose) | - |
43 | D-퓨코스 (D-Fucose) | - |
44 | L-퓨코스 (L-Fucose) | - |
45 | D-아라비톨 (D-Arabitol) | - |
46 | L-아라비톨 (L-Arabitol) | - |
47 | 포타슘 글루코네이트 (Potassium Gluconate) | + |
48 | 포타슘 2-케토글루코네이트 (Potassium 2-Ketogluconate) | - |
49 | 포타슘 5-케토글루코네이트 (Potassium 5-Ketogluconate) | - |
1 | 글라이세롤 (Glycerol) | - |
2 | 에리스리톨 (Erythritol) | - |
3 | D-아라비노즈 (D-Arabinose) | - |
4 | L-아라비노즈 (L-Arabinose) | + |
5 | D-리보스 (D-Ribose) | + |
6 | D-자일로스 (D-Xylose) | + |
7 | L-자일로스 (L-Xylose) | - |
8 | D-아도니톨 (D-Adonitol) | - |
9 | 메틸-bD-자일로피라노사이드 (Methyl-bD-Xylopyranoside) | - |
10 | D-갈락토스 (D-Galactose) | + |
11 | D-글루코스 (D-Glucose) | + |
12 | D-프록토스 (D-Fructose) | + |
13 | D-만노스 (D-Mannose) | + |
14 | L-소르보스 (L-Sorbose) | - |
15 | L-람노스 (L-Rhamnose) | - |
16 | 둘시톨 (Dulcitol) | - |
17 | 이노시톨 (Inositol) | - |
18 | D-만니톨 (D-Mannitol) | w |
19 | D-소르비톨 (D-Sorbitol) | - |
20 | 메틸-aD-만노피라노사이드 (Methyl-aD-Mannopyranoside) | - |
21 | 메틸-aD-글루코피라노사이드 (Methyl-aD-Glucopyranoside) | + |
22 | N-아세틸글루코사민 (N-Acetylglucosamine) | + |
23 | 아미그달린 (Amygdalin) | + |
24 | 아르부틴 (Arbutin) | + |
25 | 에스큘린 페릭 시트레이트 (Esculin ferric citrate) | + |
26 | 살리신 (Salicin) | + |
27 | D-셀로비오스 (D-Cellobiose) | + |
28 | D-말토스 (D-Maltose) | + |
29 | D-락토스 (D-Lactose) | + |
30 | D-멜리비오스 (D-Melibiose) | + |
31 | D-사카로스 (D-Saccharose) | + |
32 | D-트레할로스 (D-Trehalose) | + |
33 | 이눌린 (Inulin) | - |
34 | D-멜리지토스 (D-Melezitose) | - |
35 | D-라피노스 (D-Raffinose) | + |
36 | 아미돈 (전분) (Amidon (starch)) | - |
37 | 글라이코겐 (Glycogen) | - |
38 | 자일리톨 (Xylitol) | - |
39 | 젠티오비오스 (Gentiobiose) | w |
40 | D-투란노스 (D-Turanose) | + |
41 | D-락소스 (D-Lyxose) | - |
42 | D-타가토스 (D-Tagatose) | - |
43 | D-퓨코스 (D-Fucose) | - |
44 | L-퓨코스 (L-Fucose) | - |
45 | D-아라비톨 (D-Arabitol) | - |
46 | L-아라비톨 (L-Arabitol) | - |
47 | 포타슘 글루코네이트 (Potassium Gluconate) | + |
48 | 포타슘 2-케토글루코네이트 (Potassium 2-Ketogluconate) | - |
49 | 포타슘 5-케토글루코네이트 (Potassium 5-Ketogluconate) | + |
성분명 | 함량(중량%) | |||
인삼 | 발효인삼 | 홍삼 | 발효홍삼 | |
진세노사이드 Rb1 | 10.48 | 2.01 | 8.30 | 1.95 |
진세노사이드 Rb2 | 5.94 | 1.02 | 3.32 | 1.17 |
진세노사이드 Rc | 5.80 | 0.43 | 0.42 | 0.20 |
진세노사이드 Rg1 | 2.84 | 0.15 | 2.85 | 0.70 |
진세노사이드 Re | 5.74 | 0.22 | 4.85 | 0.37 |
진세노사이드 Rg3 | 1.22 | 13.67 | 3.28 | 13.25 |
진세노사이드 Rh2 | 2.05 | 29.20 | 4.58 | 30.09 |
성분명 | 함량(중량%) | |||
인삼 | 발효인삼 | 홍삼 | 발효홍삼 | |
진세노사이드 Rb1 | 10.48 | 3.30 | 8.30 | 2.63 |
진세노사이드 Rb2 | 5.94 | 2.21 | 3.32 | 1.41 |
진세노사이드 Rc | 5.80 | 1.24 | 0.42 | 0.19 |
진세노사이드 Rg1 | 2.84 | 0.98 | 2.85 | 0.85 |
진세노사이드 Re | 5.74 | 1.14 | 4.85 | 0.43 |
진세노사이드 Rg3 | 1.22 | 10.34 | 3.28 | 12.98 |
진세노사이드 Rh2 | 2.05 | 25.16 | 4.58 | 24.88 |
Claims (15)
- (a) 유산균을 인삼 또는 홍삼에 접종하는 단계; (b) 상기 유산균을 배양하는 단계; 및 (c) 상기 단계 (b)의 배양 결과물을 열처리하는 단계를 포함하는 사포닌의 전환 방법.
- (a) 유산균을 인삼 또는 홍삼에 접종하는 단계; (b) 상기 유산균을 배양하는 단계; 및 (c) 상기 단계 (b)의 배양 결과물을 열처리하는 단계를 포함하는 발효 인삼 또는 홍삼의 제조방법.
- (a) 유산균을 인삼 또는 홍삼에 접종하는 단계; (b) 상기 유산균을 배양하는 단계; 및 (c) 상기 단계 (b)의 배양 결과물을 열처리하는 단계를 포함하는 진세노사이드 Rg3 또는 Rh2의 인리치먼트(enrichment) 방법.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서, 상기 유산균은 락토코커스(Lactococcus), 락토바실러스(Lactobacillus), 류코노스톡(Leuconostoc), 프로리오니박테리움(Propionibacterium), 엔테로코커스(Enterococcus), 비피도박테리 움(Bifidobacterium), 스트렙토코커스(Streptococcus) 및 페디오코커스(Pediococcus)으로 구성된 군으로부터 선택되는 유산균인 것을 특징으로 하는 방법.
- 제 4 항에 있어서, 상기 유산균은 락토바실러스 알리멘타리우스(Lactobacillus alimentarius), 락토바실러스 사케이(Lactobacillus sakei), 락토바실러스 아시도필러스(Lactobacillus acidophilus), 락토바실러스 카세이(Lactobacillus casei), 락토바실러스 가세리(Lactobacillus gasseri), 락토바실러스 델브루엑키(Lactobacillus delbrueckii), 락토바실러스 퍼멘텀(Lactobacillus fermentum), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 류코노스톡 멘센테로이드스(Leuconostoc mensenteroides), 스트렙토코커스 서모필러스(Streptococcus thermophilus), 스트렙토코커스 락티스(Streptococcus lactis), 엔테로코커스 파에시엄(Enterococcus faecium), 엔테로코커스 파에칼리스(Enterococcus faecalis), 비피도박테리엄 비피덤(Bifidobacterium bifidum), 비피도박테리엄 인판티스(Bifidobacterium infantis), 비피도박테리엄 브라베(Bifidobacterium brave) 및 비피도박테리엄 롱검(Bifidobacterium longum)으로 구성된 군으로부터 선택되는 유산균인 것을 특징으로 하는 방법.
- 제 5 항에 있어서, 상기 유산균은 락토바실러스 알리멘타리우스(Lactobacillus alimentarius) M-2 균주(KCTC 11054 BP) 또는 류코노스톡 멘센테로이드스(Leuconostoc mensenteroides) M-3 균주(KCTC 11055 BP)인 것을 특징으로 하는 방법.
- 제 6 항에 있어서, 상기 유산균은 락토바실러스 알리멘타리우스(Lactobacillus alimentarius) M-2 균주(KCTC 11054 BP)인 것을 특징으로 하는 방법.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서, 상기 단계 (c)의 열처리는 100-150℃에서 실시하는 것을 특징으로 하는 방법.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서, 상기 단계 (c)의 열처리는 5-25분 동안 실시하는 것을 특징으로 하는 방법.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서, 상기 단계 (c)의 열처리는 1.2-1.8 기압에서 실시하는 것을 특징으로 하는 방법.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서, 상기 단계 (c)의 결과물은 상기 단계 (a)의 인삼 또는 홍삼과 비교하여 3-15배의 진세노사이드 Rg3를 포함하는 것을 특징으로 하는 방법.
- 제 11 항에 있어서, 상기 단계 (c)의 결과물은 상기 단계 (a)의 인삼 또는 홍삼과 비교하여 8-13배의 진세노사이드 Rg3를 포함하는 것을 특징으로 하는 방법.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서, 상기 단계 (c)의 결과물은 상기 단계 (a)의 인삼 또는 홍삼과 비교하여 5-20배의 진세노사이드 Rh2를 포함하는 것을 특징으로 하는 방법.
- 제 13 항에 있어서, 상기 단계 (c)의 결과물은 상기 단계 (a)의 인삼 또는 홍삼과 비교하여 10-16배의 진세노사이드 Rh2를 포함하는 것을 특징으로 하는 방 법.
- 김치로부터 분리된 락토바실러스 알리멘타리우스(Lactobacillus alimentarius) M-2 균주(KCTC 11054 BP) 또는 류코노스톡 멘센테로이드스(Leuconostoc mensenteroides) M-3 균주(KCTC 11055 BP).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070103435A KR100856790B1 (ko) | 2007-10-15 | 2007-10-15 | 발효인삼 또는 홍삼의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070103435A KR100856790B1 (ko) | 2007-10-15 | 2007-10-15 | 발효인삼 또는 홍삼의 제조방법 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060136400 Division | 2006-12-28 | 2006-12-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080063048A true KR20080063048A (ko) | 2008-07-03 |
KR100856790B1 KR100856790B1 (ko) | 2008-09-11 |
Family
ID=39815079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070103435A KR100856790B1 (ko) | 2007-10-15 | 2007-10-15 | 발효인삼 또는 홍삼의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100856790B1 (ko) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101236297B1 (ko) * | 2009-11-13 | 2013-02-22 | 한국식품연구원 | 신규한 엔테로코커스 패칼리스 케이-60 균주 및 상기 균주를 이용한 포도당 항상성 개선용 인삼 발효 추출물 및 이의 제조방법 |
KR20150113651A (ko) * | 2014-03-31 | 2015-10-08 | 송하석 | 생물전환 기술을 이용한 진세노사이드 Rg3-고함유 발효 홍삼의 제조방법 |
KR20160029955A (ko) | 2014-09-05 | 2016-03-16 | 경희대학교 산학협력단 | 진세노사이드 Rg3(S)가 인리치먼트된 발효인삼 또는 발효홍삼 제조방법 |
WO2018021889A1 (ko) * | 2016-07-29 | 2018-02-01 | 주식회사 셀투인 | 점막용 항인플루엔자 바이러스 조성물 |
KR20190111225A (ko) * | 2018-03-22 | 2019-10-02 | 주식회사 메타포뮬러 | 오메가3 지방산을 포함하는 인지 장애 질환 예방 또는 치료용 조성물 |
KR20210084874A (ko) * | 2019-12-30 | 2021-07-08 | 전북대학교산학협력단 | 진세노사이드 생물전환능을 갖는 균주 및 이를 포함하는 반추동물용 발효사료 |
KR20220046790A (ko) * | 2020-10-08 | 2022-04-15 | 영농조합법인 상생 | 사포닌의 소화흡수를 향상시킨 발효 산양산삼의 제조와 이를 이용한 발효 산양산삼 김치의 제조방법 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101037412B1 (ko) | 2008-06-27 | 2011-05-27 | 이규민 | 발효 흑홍삼 제조방법 |
KR101233987B1 (ko) * | 2010-03-18 | 2013-02-18 | 동국대학교 산학협력단 | 발효홍삼의 제조방법 |
KR101268550B1 (ko) | 2010-05-12 | 2013-06-04 | 주식회사제이엔비바이오 | 진세노사이드 증대를 위한 뿌리식물 발효 방법 |
KR102395982B1 (ko) * | 2015-01-09 | 2022-05-11 | (주)아모레퍼시픽 | 진세노사이드 함량이 증진된 인삼 추출물을 유효성분으로 포함하는 조성물 |
KR102006708B1 (ko) * | 2019-05-07 | 2019-08-02 | 양숙현 | 산양삼을 이용한 비누 조성물 및 이를 포함하는 비누 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100789678B1 (ko) * | 2005-10-07 | 2008-01-02 | (주)예당바이오 | 김치 유산균을 이용한 발효인삼 또는 발효홍삼의 제조방법 |
-
2007
- 2007-10-15 KR KR1020070103435A patent/KR100856790B1/ko active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101236297B1 (ko) * | 2009-11-13 | 2013-02-22 | 한국식품연구원 | 신규한 엔테로코커스 패칼리스 케이-60 균주 및 상기 균주를 이용한 포도당 항상성 개선용 인삼 발효 추출물 및 이의 제조방법 |
KR20150113651A (ko) * | 2014-03-31 | 2015-10-08 | 송하석 | 생물전환 기술을 이용한 진세노사이드 Rg3-고함유 발효 홍삼의 제조방법 |
KR20160029955A (ko) | 2014-09-05 | 2016-03-16 | 경희대학교 산학협력단 | 진세노사이드 Rg3(S)가 인리치먼트된 발효인삼 또는 발효홍삼 제조방법 |
WO2018021889A1 (ko) * | 2016-07-29 | 2018-02-01 | 주식회사 셀투인 | 점막용 항인플루엔자 바이러스 조성물 |
KR20180013792A (ko) * | 2016-07-29 | 2018-02-07 | 주식회사 셀투인 | 점막용 항인플루엔자 바이러스 조성물 |
KR20190111225A (ko) * | 2018-03-22 | 2019-10-02 | 주식회사 메타포뮬러 | 오메가3 지방산을 포함하는 인지 장애 질환 예방 또는 치료용 조성물 |
KR20210084874A (ko) * | 2019-12-30 | 2021-07-08 | 전북대학교산학협력단 | 진세노사이드 생물전환능을 갖는 균주 및 이를 포함하는 반추동물용 발효사료 |
KR20220046790A (ko) * | 2020-10-08 | 2022-04-15 | 영농조합법인 상생 | 사포닌의 소화흡수를 향상시킨 발효 산양산삼의 제조와 이를 이용한 발효 산양산삼 김치의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR100856790B1 (ko) | 2008-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100856790B1 (ko) | 발효인삼 또는 홍삼의 제조방법 | |
KR101822024B1 (ko) | 효소전환과 유산균 발효를 이용한 화합물 k의 함량이 강화된 발효홍삼 농축액의 제조방법 및 그 제조방법에 의해 제조된 발효홍삼 농축액을 유효성분으로 함유하는 제품 | |
KR101409761B1 (ko) | 효소전환과 유산균 발효를 이용한 화합물 k의 함량이 강화된 발효홍삼 농축액의 제조방법 및 그 제조방법에 의해 제조된 발효홍삼 농축액을 유효성분으로 함유하는 제품 | |
KR100866504B1 (ko) | 홍삼 발효용 미생물 및 발효 홍삼을 함유하는 식품 조성물 | |
US7754252B2 (en) | Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof | |
KR100997998B1 (ko) | 한국인 장-유래의 사포닌 생물전환능을 갖는 균주 및 이를 이용한 인삼 발효물의 제조방법 | |
KR101399712B1 (ko) | 신규 유발효물 및 그의 이용 | |
KR101879501B1 (ko) | 생물전환기술을 이용한 특이 진세노사이드 화합물 k 고함량 제조기술 | |
KR100935362B1 (ko) | 발효인삼 또는 홍삼의 제조방법 | |
KR101285681B1 (ko) | 사포닌 생물전환능을 갖는 균주 및 이를 이용한 체내흡수율이 증진된 발효인삼의 제조방법 | |
KR101647631B1 (ko) | 락토바실러스플란타룸 wikim18을 포함하는 진세노사이드 생물전환용 조성물 | |
WO2013176320A1 (ko) | 인체에서 유래한 유산균 락토바실러스 람노서스 hk-9 및 그를 이용한 발효물과 화장료 조성물 | |
KR101406975B1 (ko) | 신규한 진세노사이드 Rg3 인리치먼트 활성 김치 유산균 균주 및 이를 이용한 발효홍삼의 제조방법 | |
KR20210089022A (ko) | 저분자 발효홍삼 및 그의 제조방법 | |
KR20130107940A (ko) | 발효 홍삼 제조방법 | |
KR101616104B1 (ko) | 생물전환 기술을 이용한 진세노사이드 Rg3-고함유 발효 홍삼의 제조방법 | |
KR20140099104A (ko) | Rg3의 인리치먼트된 발효인삼 또는 홍삼 제조방법 | |
KR20140140899A (ko) | 화합물 k가 인리치먼트된 발효 홍삼의 제조방법 | |
KR101771488B1 (ko) | 신규한 바실러스 코아귤란스 nrr1207 균주, 이를 이용한 발효 인삼과 프로바이오틱스 생균제제 조성물 | |
KR101473634B1 (ko) | 프로바이오틱 활성을 갖는 신규 락토바실러스 속 균주 및 이를 이용한 발효홍삼 제조방법 | |
KR101583573B1 (ko) | 다단계 가열처리를 통한 홍삼 제조방법 | |
KR101465250B1 (ko) | Rg3 분해능이 없는 인변유래 신규한 락토바실러스 파라카제이 균주 및 이를 이용한 진세노사이드 Rb1 또는 F2로의 전환 방법 | |
KR101971186B1 (ko) | 비피도박테리움 애니멀리스 서브스페시스 락티스 HY8002와 비피도박테리움 아돌레센티스 HY8502의 유산균 조합을 이용한 진세노사이드 Rd가 강화된 발효홍삼 농축액의 제조방법 | |
KR101253875B1 (ko) | 진세노사이드의 생물전환능을 갖는 류코노스톡 메센테로이데스 와이엘비팔 | |
KR102466825B1 (ko) | 사포닌에 대해 생물전환능을 갖는 락토바실러스 애시도필러스 bla-9 균주, 이를 이용한 화합물 k의 함량이 증대된 발효 홍삼 추출물의 제조 방법, 이에 따른 발효 홍삼 추출물 및 이를 포함하는 건강기능식품 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120710 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130930 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140923 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150825 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170523 Year of fee payment: 9 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20170821 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180820 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190612 Year of fee payment: 12 |